The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.
The pressure against pharmacy benefit managers (PBMs) continues to build. On Tuesday, the Federal Trade Commission released ...
The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...
FTC: ‘Big 3’ Pharmacy Benefit Managers Engaged in Price Gouging, PBMs, UnitedHealth OptumRx, CVS Caremark Rx, Express Scripts ...
The nation's three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including ...
Abby Jones’ first stop of the day delivering medication was the home of 90-year-old Sarah Campbell Kier. “Come in!” yelled ...
The Iowa Pharmacy Association is calling for reform from Iowa lawmakers after 29 pharmacies closed last year, including some ...
From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 billion in revenue.
An Alabama lawmaker believes prescription care management should be a legislative priority during the upcoming session.
That reality is the very reason that's prompting lawmakers to take action against Pharmacy Benefit Managers (PBMs) in hopes of preventing further economic strain on communities. A press conference ...
According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...
A new FTC report blames Pharmacy Benefit Managers for marking up specialty drug prices, profiting $7.3 billion from cancer and HIV treatments between 2017-2022. Select whether each of the ...